National Comprehensive Cancer Network



About NCCN

Myeloid Growth Factors Panel - Disclosures as of 4/19/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

James Armitage, MD

None

Genentech, Inc.;
GlaxoSmithKline;
Seattle Genetics;
Spectrum;
Ziopharm;
Roche Laboratories, Inc.

None

Tersaro Bio, Inc.;
Tesaro Bio, Inc.

9/23/2013

Lodovico Balducci, MD

None

None

None

None

3/4/2013

Pamela Sue Becker, MD, PhD

Bristol-Myers Squibb Company;
Celgene Corporation;
Eli Lilly and Company;
Millennium Pharmaceuticals, Inc.;
sanofi-aventis U.S.

Caremark;
McKesson;
Pfizer Inc.

General Electric

None

11/10/2013

Douglas W. Blayney, MD

Bristol-Myers Squibb Company;
BlueCross Blue Shield of Michigan

National Oncology Consultants;
Physician Resource Management;
UnitedHealthcare

Abbott Laboratories;
Amgen Inc.;
Bristol-Myers Squibb Company;
Covidien AG;
Johnson & Johnson;
Express Scrips;
Mallinkridt;
United HealthCare

None

9/9/2013

Jennifer Burns

None

None

None

None

8/13/2013

Spero R. Cataland, MD

None

Alexion Pharmaceuticals, Inc.

None

None

11/7/2013

Jeffrey Crawford, MD

Amgen Inc.;
MedImmune Inc.;
GTx;
Merrimack;
Roche Laboratories, Inc.

Amgen Inc.;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Gilead;
Ono Pharmaceuticals

None

None

11/14/2013

Peter Curtin, MD

Onconova

None

None

None

11/21/2013

Mary Dwyer, MS

None

None

None

None

3/7/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Elizabeth A. Griffiths, MD

Astex Pharmaceuticals

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Astex Pharmaceuticals;
Incyte

None

None

4/10/2014

Maria Ho, PhD

None

None

None

None

8/14/2013

Shannon M. Hough, PharmD, BCOP

None

None

None

None

1/30/2014

Dwight D. Kloth, PharmD, FCCP, BCOP

None

Amgen Inc.;
Eisai Inc.;
Teva Oncology

None

None

7/22/2013

David J. Kuter, MD, PhD

None

Amgen Inc.;
3BIOS;
Amgen Australia;
caremark;
Kirin

None

None

1/21/2014

Gary H. Lyman, MD, MPH, FRCP

Amgen Inc.

None

None

None

9/6/2013

Joan S. McClure, MS

None

None

None

None

8/13/2013

Brandon McMahon, MD

None

None

None

None

3/11/2013

Jacqueline Parpal, PharmD

None

None

None

None

10/24/2013

Hope S. Rugo, MD

None

None

None

None

10/14/2013

Ayman A. Saad, MD

None

IMS Consulting Group

None

None

8/21/2013

Lee S. Schwartzberg, MD, FACP

Bristol-Myers Squibb Company;
Eisai Inc.

Amgen Inc.;
Eisai Inc.;
Genentech, Inc.;
GlaxoSmithKline

None

None

8/26/2013

Sepideh Shayani, PharmD, BCOP

None

None

None

None

1/20/2014

Courtney Smith

None

None

Johnson & Johnson;
OPKO

None

3/4/2014

Mahsa Talbott, PharmD

None

None

None

None

12/12/2012

Sarika Trikha

None

None

None

None

8/13/2013

Saroj Vadhan-Raj, MD

Amgen Inc.

Amgen Inc.;
Hospira

None

None

4/9/2013

Martha Wadleigh, MD

None

None

None

None

1/28/2014

Peter Westervelt, MD, PhD

Celgene Corporation

None

None

Celgene Corporation

4/3/2014

Michael Westmoreland, PharmD

None

Merck & Co., Inc.

None

None

9/20/2013